| 标题 |
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib‐refractory ALK ‐positive NSCLC from a phase II study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Cancer Communications 作者:Jing Zheng; Tao Wang; Yunpeng Yang; Jie Huang; Jifeng Feng; et al 出版日期:2024-02-29 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)